Search

Search Constraints

You searched for: Author/Creator Zerbib, Yoann

Search Results

1. Abnormal laboratory findings and plasma concentration monitoring of lopinavir and ritonavir in COVID‐19. Issue 3 (3rd August 2020)

2. Doppler Echocardiographic Indices Are Specific But Not Sensitive to Predict Pulmonary Artery Occlusion Pressure in Critically Ill Patients Under Mechanical Ventilation. Issue 1 (January 2021)

4. Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19. Issue 6 (June 2022)

5. Prospective validation study of prognostic biomarkers to predict adverse outcomes in patients with COVID-19: a study protocol. Issue 1 (6th January 2021)

6. Prospective validation study of prognostic biomarkers to predict adverse outcomes in patients with COVID-19: a study protocol. Issue 1 (6th January 2021)

7. Prospective validation study of prognostic biomarkers to predict adverse outcomes in patients with COVID-19: a study protocol. Issue 1 (6th January 2021)

8. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial. Issue 2 (February 2022)

9. The urine biomarkers TIMP2 and IGFBP7 can identify patients who will experience severe acute kidney injury following a cardiac arrest: A prospective multicentre study. (August 2019)